Session Time: 6:00pm-7:00pm
Presentation Time: 6:00pm-7:00pm
Location: Hall C & D
*Purpose: Our institution, a freestanding pediatric hospital (FPH) has a large pediatric liver transplant (LT) experience. Our aim was to analyze our experience with other FPHs and compare it to the UNOS experience.
*Methods: We analyzed 551 children listed for and 528 recipients of LT at our institution between 1987-2016 and the UNOS database which included 5,273 children listed / 4,959 children transplanted in FPHs and 18,090 children listed / 10,832 children transplanted in other settings. Kaplan-Meier and multivariate analyses were performed.
*Results: Our institution achieved pediatric LT survivals of 91% 1-year, 87% 5-year, 84% 10-year, and 77% 20-year survival compared to 85% 1-year, 79% 5-year, 76% 10-year, and 68% 20-year survival at non-FPHs (p<0.001). Our institution and other FPHs had superior waitlist survival, probability of transplant, and posttransplant survival compared to children treated at non-FPHs (p<0.001). After adjusting for age, diagnosis, GFR, height, serum albumin, listing status, PELD score, serum sodium, and weight, pediatric LT performed in a FPH has a 67% decreased chance of dying pretransplant and a 16% increased chance of surviving LT.
*Conclusions: We report one of the largest institutional experiences in pediatric LT and demonstrate that superior patient survival, probability of transplant and waitlist mortality are achieved at our institution and other FPHs.
To cite this abstract in AMA style:Rana A, Kueht M, Galvan N, Cotton R, O'Mahony C, Goss J. 500 Pediatric Liver Transplants At A Freestanding Pediatric Hospital – Where It Is Done Best [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/500-pediatric-liver-transplants-at-a-freestanding-pediatric-hospital-where-it-is-done-best/. Accessed July 24, 2021.
« Back to 2019 American Transplant Congress